CD19 and COVID-19: Moreover, the frequencies of CD19+PD-1+ B cells > 13.0% and >10.2% for CD19+PD-L1+ B cells on day 7 of hospitalization in the ICU were significantly associated with fatal outcomes in patients with COVID-19.